Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment

Metabolomics-based technologies map in vivo biochemical changes that may be used as early indicators of pathological abnormalities prior to the development of clinical symptoms in neurological conditions. Metabolomics may also reveal biochemical pathways implicated in tissue dysfunction and damage a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rispoli, Marianna Gabriella, Valentinuzzi, Silvia, De Luca, Giovanna, Del Boccio, Piero, Federici, Luca, Di Ioia, Maria, Digiovanni, Anna, Grasso, Eleonora Agata, Pozzilli, Valeria, Villani, Alessandro, Chiarelli, Antonio Maria, Onofrj, Marco, Wise, Richard G., Pieragostino, Damiana, Tomassini, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541167/
https://www.ncbi.nlm.nih.gov/pubmed/34681773
http://dx.doi.org/10.3390/ijms222011112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541167/
https://www.ncbi.nlm.nih.gov/pubmed/34681773
http://dx.doi.org/10.3390/ijms222011112

Ejemplares similares